Cargando…
Cost of managing an episode of relapse in multiple sclerosis in the United States
BACKGROUND: The purpose of this study was to determine the direct medical US cost of managing multiple sclerosis relapses. METHODS: Direct data analysis and cost modeling were employed to derive typical resource use profiles and costs in 2002 US dollars, from the perspective of a third-party payer r...
Autores principales: | O'Brien, Judith A, Ward, Alexandra J, Patrick, Amanda R, Caro, Jaime |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC201004/ https://www.ncbi.nlm.nih.gov/pubmed/12952552 http://dx.doi.org/10.1186/1472-6963-3-17 |
Ejemplares similares
-
Cost of managing complications resulting from type 2 diabetes mellitus in Canada
por: O'Brien, Judith A, et al.
Publicado: (2003) -
Cost Per Relapse Avoided for Ozanimod Versus Other Selected Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis in the United States
por: Kantor, Daniel, et al.
Publicado: (2023) -
Hospitalization for pertussis: profiles and case costs by age
por: O'Brien, Judith A, et al.
Publicado: (2005) -
Episodic Past, Future, and counterfactual thinking in Relapsing-Remitting Multiple sclerosis
por: Ayala, Oscar Daniel, et al.
Publicado: (2022) -
Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States
por: Carlson, Josh J., et al.
Publicado: (2018)